サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463655

中南米の脳脊髄液管理：2030年までの市場予測 - 地域分析 - 製品別、エンドユーザー別

South & Central America Cerebrospinal Fluid Management Market Forecast to 2030 - Regional Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

出版日
ページ情報
英文 103 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
中南米の脳脊髄液管理：2030年までの市場予測 - 地域分析 - 製品別、エンドユーザー別
出版日: 2024年01月23日
発行: The Insight Partners
ページ情報: 英文 103 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の脳脊髄液管理市場は、2022年に9,252万米ドルと評価され、2030年には1億2,389万米ドルに達すると予測され、2022年から2030年までのCAGRは3.7%で成長すると予測されています。

神経疾患治療における髄液管理への注目の高まりが中南米の脳脊髄液管理市場を後押し

CSFパラメータは、成人患者の神経疾患のバイオマーカーとして広く評価されています。CSF中の循環マイクロRNAは、さまざまな神経疾患の診断に有望なバイオマーカーです。パーキンソン病（PD）、アルツハイマー病（AD）、てんかん、けいれんなどの神経疾患では、しばしばCSFパラメータが変化します。Nature』誌に掲載された論文によると、PDと診断された患者では、76種類の髄液蛋白質が正常な人と比べて構造的に変化していることが判明しました。この研究はまた、これらのCSFタンパク質が疾患の診断や治療のためのバイオマーカーとして使用できることを示唆しています。PDは、認知機能障害と運動機能の低下を伴う神経変性疾患です。2022年に発表された世界保健機関（WHO）の報告書によると、PDの有病率は過去25年間で倍増し、60歳以上の世界人口の約1％が罹患しています。同様に、発作やてんかんの状態にある患者では、タンパク質や乳酸値のような髄液パラメータのいくつかが変化します。そのため、発作やてんかんの治療に髄液パラメーターを使用するために、さまざまな研究開発が行われています。さらに、CSFを用いたアルツハイマー病検出のためのさまざまなCSFアッセイが市場に出回っているにもかかわらず、検出および治療目的のバイオマーカーに対するニーズは満たされていないです。アルツハイマー病やPDの症例検出が増加するにつれて、髄液漏れの症例が増加する可能性があるため、髄液管理デバイスの需要が増加しています。したがって、神経疾患の有病率の増加が、これらの疾患の治療に髄液管理製品を使用するための研究開発活動に拍車をかけています。

中南米の脳脊髄液管理市場の概要

中南米の脳脊髄液管理市場は、ブラジル、アルゼンチン、その他中南米に区分されます。この地域における市場の成長は、医療機器の輸入増加、高度な医療技術を必要とするヘルスケアシステムの開発、高齢者人口の増加によってもたらされるいくつかの機会によって期待されています。

中南米の脳脊髄液管理市場の収益と2030年までの予測（US$Mn）

中南米の脳脊髄液管理市場のセグメンテーション

中南米の脳脊髄液管理市場は、製品、エンドユーザー、国に区分されます。

製品別では、中南米の脳脊髄液管理市場はCSFシャントとCSFドレナージシステムに二分されます。2022年にはCSFシャントセグメントが大きな市場シェアを占めています。

エンドユーザー別に見ると、中南米の脳脊髄液管理市場は病院、クリニック、外来手術センター、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別に見ると、中南米の脳脊髄液管理市場はブラジル、アルゼンチン、その他中南米に区分されます。ブラジルは2022年の中南米の脳脊髄液管理市場シェアを独占しました。

B.Braun SE、Integra LifeSciences Holdings Corp、Medtronic Plc、Spiegelberg GmbH &Co KGなどは、中南米の脳脊髄液管理市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の脳脊髄液管理市場の情勢

  • 中南米のPEST分析

第5章 中南米の脳脊髄液管理市場：主要産業力学

  • 市場促進要因
    • 脳脊髄液漏出症例の増加
    • 脳脊髄液に関連する課題増加に対する政府の取り組み
  • 市場抑制要因
    • 故障や誤作動のリスク
  • 市場機会
    • 神経疾患治療における髄液管理への注目の高まり
  • 今後の動向
    • スマート脳脊髄液シャントの開発
  • 影響分析

第6章 脳脊髄液管理市場：中南米市場分析

  • 中南米の脳脊髄液管理市場収益、2022年～2030年

第7章 中南米の脳脊髄液管理市場 - 収益と2030年までの予測：製品別

  • 市場収益シェア、2022年および2030年
  • 髄液シャント
  • 髄液ドレナージシステム

第8章 中南米の脳脊髄液管理市場 - 収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院
  • 診療所
  • 外来手術センター
  • その他

第9章 中南米の脳脊髄液管理市場：国別分析

  • 中南米の脳脊髄液管理市場：国別分析
  • ブラジル
  • アルゼンチン
  • その他中南米

第10章 業界情勢

  • 中南米の脳脊髄液管理市場における成長戦略、2020年～2023年
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Medtronic Plc
  • Integra LifeSciences Holdings Corp
  • B. Braun SE
  • Spiegelberg GmbH & Co KG

第12章 付録

図表

List Of Tables

  • Table 1. South & Central America Cerebrospinal Fluid Management Market Segmentation
  • Table 2. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 4. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 5. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 6. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 7. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 8. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 9. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 10. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 11. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 12. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 13. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Recent Inorganic Growth Strategies in the South & Central America Cerebrospinal Fluid Management Market
  • Table 15. Recent Organic Growth Strategies in The South & Central America Cerebrospinal Fluid Management Market
  • Table 16. Glossary of Terms, South & Central America Cerebrospinal Fluid Management Market

List Of Figures

  • Figure 1. South & Central America Cerebrospinal Fluid Management Market Segmentation, By Country
  • Figure 2. South & Central America - PEST Analysis
  • Figure 3. South & Central America Cerebrospinal Fluid Management Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. South & Central America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. South & Central America Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 - 2030
  • Figure 7. South & Central America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. CSF Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Ventriculoperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Ventriculoatrial Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Ventriculopleural Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Lumboperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. CSF Drainage Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. External Ventricular Drainage (EVD) Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Lumbar Drainage (LD) Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. South & Central America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 17. Hospitals: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Clinics: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Ambulatory Surgical Centers: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. South & Central America Cerebrospinal Fluid Management Market, by Key Country-Revenue (2022) ($Mn)
  • Figure 22. South & Central America Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 23. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Growth Strategies in The South & Central America Cerebrospinal Fluid Management Market, 2020-2023
目次
Product Code: TIPRE00027992

The South & Central America cerebrospinal fluid management market was valued at US$ 92.52 million in 2022 and is expected to reach US$ 123.89 million by 2030; it is estimated to grow at a CAGR of 3.7% from 2022 to 2030.

Increasing Focus on CSF Management in Neurological Disease Treatments Fuels the South & Central America Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson's Disease (PD), Alzheimer's Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer's disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer's disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

South & Central America Cerebrospinal Fluid Management Market Overview

The cerebrospinal fluid management market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The growth of the market in the region is expected due to several opportunities offered by increasing import of medical devices, growing developments of healthcare systems that demand advanced medical technologies and growing geriatric population.

South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

South & Central America Cerebrospinal Fluid Management Market Segmentation

The South & Central America cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the South & Central America cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the South & Central America cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South & Central America cerebrospinal fluid management market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America cerebrospinal fluid management market share in 2022.

B. Braun SE, Integra LifeSciences Holdings Corp, Medtronic Plc, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the South & Central America cerebrospinal fluid management market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Cerebrospinal Fluid Management Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis

5. South & Central America Cerebrospinal Fluid Management Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
    • 5.1.2 Government Initiatives for Addressing Growing Challenges Associated with CSF
  • 5.2 Market Restraints
    • 5.2.1 Risk of Failure and Malfunctioning
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
  • 5.4 Future Trends
    • 5.4.1 Development of Smart Cerebrospinal Fluid Shunts
  • 5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - South & Central America Market Analysis

  • 6.1 South & Central America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 South & Central America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 CSF Shunts
    • 7.3.1 Overview
    • 7.3.2 CSF Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Ventriculoperitoneal Shunts
      • 7.3.3.1 Overview
      • 7.3.3.2 Ventriculoperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Ventriculoatrial Shunts
      • 7.3.4.1 Overview
      • 7.3.4.2 Ventriculoatrial Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Ventriculopleural Shunts
      • 7.3.5.1 Overview
      • 7.3.5.2 Ventriculopleural Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Lumboperitoneal Shunts
      • 7.3.6.1 Overview
      • 7.3.6.2 Lumboperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 CSF Drainage Systems
    • 7.4.1 Overview
    • 7.4.2 CSF Drainage Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 External Ventricular Drainage (EVD) Systems
      • 7.4.3.1 Overview
      • 7.4.3.2 External Ventricular Drainage (EVD) Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Lumbar Drainage (LD) Systems
      • 7.4.4.1 Overview
      • 7.4.4.2 Lumbar Drainage (LD) Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 South & Central America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinics
    • 8.4.1 Overview
    • 8.4.2 Clinics: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Ambulatory Surgical Centers
    • 8.5.1 Overview
    • 8.5.2 Ambulatory Surgical Centers: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Cerebrospinal Fluid Management Market - Country Analysis

  • 9.1 Overview
      • 9.1.1.1 South & Central America Cerebrospinal Fluid Management Market, by Country
      • 9.1.1.2 Brazil
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 Brazil: South & Central America Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.2.3.1 Brazil: South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.2.3.2 Brazil: South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.2.4 Brazil: South & Central America Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.3 Argentina
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Argentina: South & Central America Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.3.3.1 Argentina: South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.3.3.2 Argentina: South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.3.4 Argentina: South & Central America Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.4 Rest of South & Central America
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.4.3.1 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.4.3.2 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.4.4 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in The South & Central America Cerebrospinal Fluid Management Market, 2020-2023
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Integra LifeSciences Holdings Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 B. Braun SE
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Spiegelberg GmbH & Co KG
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms